U.S. Ophthalmic Drug Delivery Systems Market Size & Outlook

The ophthalmic drug delivery systems market in the United States is expected to reach a projected revenue of US$ 10,438.2 million by 2030. A compound annual growth rate of 6% is expected of the United States ophthalmic drug delivery systems market from 2026 to 2030.
Revenue, 2025 (US$M)
$7,783.1
Forecast, 2030 (US$M)
$10,438.2
CAGR, 2026 - 2030
6%
Report Coverage
U.S.

U.S. ophthalmic drug delivery systems market, 2018-2030 (US$M)

U.S.

U.S. ophthalmic drug delivery systems market highlights

  • The U.S. ophthalmic drug delivery systems market generated a revenue of USD 7,783.1 million in 2025 and is expected to reach USD 10,438.2 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 6% from 2026 to 2030.
  • In terms of segment, eye drops was the largest revenue generating technology in 2025.
  • Contact lenses is the most lucrative technology segment registering the fastest growth during the forecast period.

Ophthalmic drug delivery systems market data book summary

Market revenue in 2025USD 7,783.1 million
Market revenue in 2030USD 10,438.2 million
Growth rate6% (CAGR from 2025 to 2030)
Largest segmentEye drops
Fastest growing segmentContact lenses
Historical data2018 - 2024
Base year2025
Forecast period2026 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEye drops, Contact lenses, Punctal plugs, Episcleral Implants, Intravitreal Implants, Injectable Particulate Systems, Iontophoresis, Micro-Electromechanical, Nano careers, Nano microparticles, Microneedles, Hydrogels
Key market players worldwideOcular Therapeutix Inc, Allergan, Santen Pharmaceutical Co Ltd, Clearside Biomedical Inc, Oculis Holding AG, Bausch Health Companies Inc, AptarGroup Inc

Other key industry trends

  • In terms of revenue, U.S. accounted for 45.8% of the global ophthalmic drug delivery systems market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. ophthalmic drug delivery systems market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 1,673.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ophthalmic Drug Delivery Systems Market Companies

Name Profile # Employees HQ Website

U.S. ophthalmic drug delivery systems market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drug delivery systems market will help companies and investors design strategic landscapes.


Eye drops was the largest segment with a revenue share of 20.15% in 2025. Horizon Databook has segmented the U.S. ophthalmic drug delivery systems market based on eye drops, contact lenses, punctal plugs, episcleral implants, intravitreal implants, injectable particulate systems, iontophoresis, micro-electromechanical, nano careers, nano microparticles, microneedles, hydrogels covering the revenue growth of each sub-segment from 2018 to 2030.


  • U.S. Ophthalmic Drug Delivery Systems Technology Outlook (Revenue, USD Million, 2018-2030)
    • Eye drops
    • Contact lenses
    • Punctal plugs
    • Episcleral Implants
    • Intravitreal Implants
    • Injectable Particulate Systems
    • Iontophoresis
    • Micro-Electromechanical
    • Nano careers
    • Nano microparticles
    • Microneedles
    • Hydrogels
    • Others
  • U.S. Ophthalmic Drug Delivery Systems Delivery Route Outlook (Revenue, USD Million, 2018-2030)
    • Intraocular
    • Intravitreal
    • Intracameral
  • U.S. Ophthalmic Drug Delivery Systems Production Technology Outlook (Revenue, USD Million, 2018-2030)
    • Electrospinning
    • 3D printing
    • Extrusion
    • Formulation
    • Micro patterning
    • Compression molding
    • Others
  • U.S. Ophthalmic Drug Delivery Systems Material Outlook (Revenue, USD Million, 2018-2030)
    • Liposomes
    • Collagen
    • PLA-PEG
    • PDO/PVA
    • Hydrogels
    • TMC
    • Polyorthoesters
    • PLGA
    • Polycaprolactone
    • Fatty acids
    • Others

Reasons to subscribe to U.S. ophthalmic drug delivery systems market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. ophthalmic drug delivery systems market databook

  • Our clientele includes a mix of ophthalmic drug delivery systems market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. ophthalmic drug delivery systems market, including forecasts for subscribers. This country databook contains high-level insights into U.S. ophthalmic drug delivery systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. ophthalmic drug delivery systems market size, by technology, 2018-2030 (US$M)

U.S. Ophthalmic Drug Delivery Systems Market Share, 2025 & 2030 (US$M)

U.S. ophthalmic drug delivery systems market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more